KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Raw Materials (2018 - 2025)

Historic Raw Materials for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to $24.7 million.

  • Twist Bioscience's Raw Materials rose 5386.44% to $24.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $24.7 million, marking a year-over-year increase of 5386.44%. This contributed to the annual value of $20.2 million for FY2025, which is 1660.31% up from last year.
  • Per Twist Bioscience's latest filing, its Raw Materials stood at $24.7 million for Q4 2025, which was up 5386.44% from $20.2 million recorded in Q3 2025.
  • In the past 5 years, Twist Bioscience's Raw Materials ranged from a high of $33.6 million in Q1 2023 and a low of $11.4 million during Q1 2021
  • Moreover, its 5-year median value for Raw Materials was $22.9 million (2023), whereas its average is $23.5 million.
  • Per our database at Business Quant, Twist Bioscience's Raw Materials soared by 20519.11% in 2021 and then tumbled by 3592.36% in 2024.
  • Over the past 5 years, Twist Bioscience's Raw Materials (Quarter) stood at $30.3 million in 2021, then grew by 10.62% to $33.6 million in 2022, then fell by 29.22% to $23.8 million in 2023, then crashed by 32.51% to $16.0 million in 2024, then soared by 53.86% to $24.7 million in 2025.
  • Its Raw Materials was $24.7 million in Q4 2025, compared to $20.2 million in Q3 2025 and $17.5 million in Q2 2025.